2006
DOI: 10.1016/j.transproceed.2006.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Administration of Donor-Derived Mesenchymal Stem Cells Can Prolong the Survival of Rat Cardiac Allograft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
78
0
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 112 publications
(80 citation statements)
references
References 26 publications
1
78
0
1
Order By: Relevance
“…Bone marrow stromal cells (BMSCs) have recently been shown to suppress harmful immune responses in patients with acute graftversus-host disease (4,5) and in several animal models of allogeneic rejection (6)(7)(8), a variety of autoimmune diseases (9)(10)(11), and lung injury (12)(13)(14)(15). The authors of many of these studies concluded that BMSC-driven immunosuppression results from a shift in Th1/Th2 balance (8,16,17).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Bone marrow stromal cells (BMSCs) have recently been shown to suppress harmful immune responses in patients with acute graftversus-host disease (4,5) and in several animal models of allogeneic rejection (6)(7)(8), a variety of autoimmune diseases (9)(10)(11), and lung injury (12)(13)(14)(15). The authors of many of these studies concluded that BMSC-driven immunosuppression results from a shift in Th1/Th2 balance (8,16,17).…”
mentioning
confidence: 99%
“…The authors of many of these studies concluded that BMSC-driven immunosuppression results from a shift in Th1/Th2 balance (8,16,17). During BMSC treatment, Th1 responses appear to be decreasing while Th2 responses begin to dominate.…”
mentioning
confidence: 99%
“…The immunosuppressive effect and low immunogenicity of mesenchymal stem cells (MSCs) make them ideal candidates for immunosuppressive strategies [3,4]. Adult MSCs have been used widely in the allogeneic heart [5][6][7][8][9][10][11], liver [12], islet [13][14][15][16][17], kidney [18,19], and composite tissue transplants [20,21]. Bone marrow mesenchymal stem cells (BM-MSCs) alone prolong heart allograft survival [8].…”
Section: Introductionmentioning
confidence: 99%
“…A maioria dos estudos para o tratamento do infarto do miocárdio emprega a utilização de células adultas, como o mioblasto esquelético 6,7 , de células mesenquimais [8][9][10] , e de células mononucleares da medula óssea, obtidas por meio de punção da medula óssea 11 .…”
Section: Introductionunclassified